New Triple-Action cancer drug enters human testing

NCT ID NCT06741644

Recruiting now Disease control Sponsor: CStone Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study testing a new experimental drug called CS2009 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the cancer. The drug is designed to target three different pathways that cancers use to grow and evade the immune system.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alfred Hospital (Alfred Health)
RECRUITING

Melbourne, Australia
Anhui Provincial Hospital
RECRUITING

Hefei, China
Austin Hospital (Austin Health)
RECRUITING

Melbourne, Australia
Beijing Cancer Hospital
RECRUITING

Beijing, China
Blacktown Hospital
RECRUITING

Sydney, Australia
Central Hospital Affiliated to Shandong First Medical University
RECRUITING

Jinan, China
Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, China
Fujian Cancer Hospital
RECRUITING

Fuzhou, China
Harbin Medical University Cancer Hospital
RECRUITING

Harbin, China
Henan Cancer Hospital
RECRUITING

Zhengzhou, China
Hunan Cancer Hospital
NOT_YET_RECRUITING

Changsha, China
Icon Cancer Centre South Brisbane
RECRUITING

South Brisbane, Australia
Jilin Cancer Hospital
RECRUITING

Changchun, China
Linyi Cancer Hospital
RECRUITING

Linyi, China
Macquarie University Hospital
RECRUITING

Sydney, Australia
Monash Medical Centre (Monash Health)
RECRUITING

Melbourne, Australia
Nanjing Drum Tower Hospital
RECRUITING

Nanjing, China
Peter Maccallum Cancer Centre Research
NOT_YET_RECRUITING

Melbourne, Australia
Scientia Clinical Research Ltd
RECRUITING

Sydney, Australia
Shanghai East Hospital
RECRUITING

Shanghai, China
Shanghai Pulmonary Hospital
RECRUITING

Shanghai, China
Sichuan Cancer Hospital
RECRUITING

Chengdu, China
Sun Yat-Sen University Cancer Center
NOT_YET_RECRUITING

Guangzhou, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
RECRUITING

Guangzhou, China
The First Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, China
The First Affiliated Hospital of Zhengzhou University
RECRUITING

Zhengzhou, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Wuhan, China
West China Hospital of Sichuan University
RECRUITING

Chengdu, China
Xuzhou Central Hospital
RECRUITING

Xuzhou, China
Zhejiang Cancer Hospital
RECRUITING

Hangzhou, China

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS